Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2011-02-01 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: NOGENT-SUR-MARNE (94130), Val-de-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE DE BALTARD : revenue, balance sheet and financial ratios
SELAS PHARMACIE DE BALTARD is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in NOGENT-SUR-MARNE (94130),
this company of category PME
shows in 2023 a net income positive of 237 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE DE BALTARD (SIREN 529775850)
Indicator
2023
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
236 676 €
216 023 €
163 813 €
101 752 €
69 882 €
76 102 €
85 184 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, SELAS PHARMACIE DE BALTARD generates positive net income of 237 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 85 k€ -> 237 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
236 676 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 79%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 50%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
78.644%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
49.58%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELAS PHARMACIE DE BALTARD
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
Debt ratio
253.407
231.416
206.021
187.808
157.918
125.825
78.644
Financial autonomy
24.974
26.746
29.724
31.246
33.683
38.517
49.58
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
78.642023
2020
2021
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average-8 pts over 3 years
In 2023, the debt ratio of SELAS PHARMACIE DE BALTARD (78.64) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
49.58%2023
2020
2021
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good+12 pts over 3 years
In 2023, the financial autonomy of SELAS PHARMACIE DE BALTARD (49.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 259.36. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
259.364
Liquidity indicators evolution SELAS PHARMACIE DE BALTARD
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2023
Liquidity ratio
148.135
167.814
184.186
177.119
168.871
185.858
259.364
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
259.362023
2020
2021
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Good+28 pts over 3 years
In 2023, the liquidity ratio of SELAS PHARMACIE DE BALTARD (259.36) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of SELAS PHARMACIE DE BALTARD in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of SELAS PHARMACIE DE BALTARD is estimated at
2 792 652 €
(range 1 698 345€ - 3 925 843€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1698k€2792k€3925k€
2 792 652 €Range: 1 698 345€ - 3 925 843€
NAF 5 année 2023
Valuation method used
Net Income Multiple
236 676 €
×
11.8x
=2 792 653 €
Range: 1 698 346€ - 3 925 843€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE DE BALTARD with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE DE BALTARD
What is the revenue of SELAS PHARMACIE DE BALTARD ?
The revenue of SELAS PHARMACIE DE BALTARD is not publicly disclosed (confidential accounts filed with INPI).
Is SELAS PHARMACIE DE BALTARD profitable?
Yes, SELAS PHARMACIE DE BALTARD generated a net profit of 237 k€ in 2023.
Where is the headquarters of SELAS PHARMACIE DE BALTARD ?
The headquarters of SELAS PHARMACIE DE BALTARD is located in NOGENT-SUR-MARNE (94130), in the department Val-de-Marne.
Where to find the tax return of SELAS PHARMACIE DE BALTARD ?
The tax return of SELAS PHARMACIE DE BALTARD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE DE BALTARD operate?
SELAS PHARMACIE DE BALTARD operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart